Overview

A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01

Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This is a continuation trial of LymphoStat-B™ to evaluate the long-term safety in subjects with Rheumatoid Arthritis that completed study LBRA01 and benefitted from treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Human Genome Sciences Inc.
Treatments:
Belimumab